Shandong Realcan Pharmaceutical Co Ltd (002589) — Cash Flow-to-Debt Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-15.60 Million could theoretically repay 0% of its total liabilities (CN¥9.87 Billion) in one year. See Shandong Realcan Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Realcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Shandong Realcan Pharmaceutical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Shandong Realcan Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Year-by-year debt coverage analysis for Shandong Realcan Pharmaceutical Co Ltd. Check 002589 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CN¥13.76 Million | CN¥8.95 Billion | ▼ -90.1% |
| 2024 | 0.02x | CN¥160.44 Million | CN¥10.32 Billion | ▲ +108.8% |
| 2023 | 0.01x | CN¥82.47 Million | CN¥11.07 Billion | ▼ -82.1% |
| 2022 | 0.04x | CN¥523.07 Million | CN¥12.58 Billion | ▲ +56.8% |
| 2021 | 0.03x | CN¥442.95 Million | CN¥16.70 Billion | ▲ +38.3% |
| 2020 | 0.02x | CN¥414.96 Million | CN¥21.65 Billion | ▼ -79.7% |
| 2019 | 0.09x | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +1200.2% |
| 2018 | -0.01x | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +93.9% |
| 2017 | -0.14x | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +35.1% |
| 2016 | -0.22x | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -152.5% |
| 2015 | -0.09x | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -101.2% |
| 2014 | -0.04x | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +56.6% |
| 2013 | -0.10x | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -26.5% |
| 2012 | -0.08x | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +77.2% |
| 2011 | -0.34x | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -668.9% |
| 2010 | 0.06x | CN¥70.56 Million | CN¥1.18 Billion | ▼ -21.7% |
| 2009 | 0.08x | CN¥61.38 Million | CN¥805.78 Million | ▲ +192.2% |
| 2008 | -0.08x | CN¥-49.88 Million | CN¥603.64 Million | — |